- Home
- RNAC vs GCO Comparison
RNAC vs GCO Comparison
Compare RNAC & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAC
- GCO
- Stock Information
- Founded
- RNAC 2007
- GCO 1924
- Country
- RNAC United States
- GCO United States
- Employees
- RNAC N/A
- GCO N/A
- Industry
- RNAC Biotechnology: Pharmaceutical Preparations
- GCO Clothing/Shoe/Accessory Stores
- Sector
- RNAC Health Care
- GCO Consumer Discretionary
- Exchange
- RNAC Nasdaq
- GCO Nasdaq
- Market Cap
- RNAC 242.4M
- GCO 238.4M
- IPO Year
- RNAC 2016
- GCO N/A
- Fundamental
- Price
- RNAC $10.38
- GCO $20.49
- Analyst Decision
- RNAC Strong Buy
- GCO Hold
- Analyst Count
- RNAC 6
- GCO 2
- Target Price
- RNAC $41.25
- GCO $24.50
- AVG Volume (30 Days)
- RNAC 71.7K
- GCO 343.5K
- Earning Date
- RNAC 08-07-2025
- GCO 06-04-2025
- Dividend Yield
- RNAC N/A
- GCO N/A
- EPS Growth
- RNAC N/A
- GCO N/A
- EPS
- RNAC N/A
- GCO N/A
- Revenue
- RNAC $34,173,000.00
- GCO $2,341,438,000.00
- Revenue This Year
- RNAC N/A
- GCO $2.53
- Revenue Next Year
- RNAC N/A
- GCO $2.01
- P/E Ratio
- RNAC N/A
- GCO N/A
- Revenue Growth
- RNAC 31.91
- GCO 1.85
- 52 Week Low
- RNAC $8.46
- GCO $16.19
- 52 Week High
- RNAC $28.83
- GCO $44.80
- Technical
- Relative Strength Index (RSI)
- RNAC 51.34
- GCO 43.18
- Support Level
- RNAC $10.01
- GCO $20.89
- Resistance Level
- RNAC $11.78
- GCO $22.46
- Average True Range (ATR)
- RNAC 0.70
- GCO 0.97
- MACD
- RNAC 0.12
- GCO -0.17
- Stochastic Oscillator
- RNAC 48.65
- GCO 11.01
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.